Bioasis Technologies Inc.
BIOAF · OTC
11/30/2022 | 8/31/2022 | 5/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $149 | $120 | $0 | $0 |
| % Growth | 23.7% | – | – | – |
| Cost of Goods Sold | $221 | $31 | $14 | $14 |
| Gross Profit | -$72 | $89 | -$14 | -$14 |
| % Margin | -48.3% | 74% | – | – |
| R&D Expenses | $221 | $246 | $181 | $321 |
| G&A Expenses | $627 | $774 | $449 | $525 |
| SG&A Expenses | $627 | $774 | $449 | $525 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $848 | $1,020 | $630 | $846 |
| Operating Income | -$699 | -$900 | -$630 | -$2,137 |
| % Margin | -469.2% | -747% | – | – |
| Other Income/Exp. Net | -$66 | -$191 | $396 | $279 |
| Pre-Tax Income | -$986 | -$1,090 | -$233 | -$567 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$986 | -$1,090 | -$233 | -$567 |
| % Margin | -661.8% | -905.2% | – | – |
| EPS | -0.013 | -0.014 | -0.003 | -0.008 |
| % Growth | 9.4% | -334.4% | 59% | – |
| EPS Diluted | -0.013 | -0.014 | -0.003 | -0.008 |
| Weighted Avg Shares Out | 78,213 | 78,213 | 72,914 | 72,914 |
| Weighted Avg Shares Out Dil | 78,213 | 78,213 | 72,914 | 72,914 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $212 | $230 | $247 | $256 |
| Depreciation & Amortization | $35 | $31 | $14 | $14 |
| EBITDA | -$664 | -$829 | $27 | -$1,588 |
| % Margin | -445.8% | -688% | – | – |